By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Acquisition and development of small molecule therapeutics for the treatment of serious diseases409.66K100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States409.66K100.00%